Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
8(100.0%)
8Total
N/A(8)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT05273385Not ApplicableTerminated

Efficacy of the Nanodropper Device on Intraocular Pressure in Patients With Glaucoma

Role: collaborator

NCT06748092Not ApplicableRecruiting

Clinical Validation of iCare IC1000 Tonometer

Role: lead

NCT07156630Not ApplicableCompleted

Quick Measure Study for iCare ST500 and iCare IC200

Role: lead

NCT07022054Not ApplicableCompleted

iCare IC1000 Alignment Study

Role: lead

NCT06450587Not ApplicableCompleted

Intraocular Pressure Data Collection With Tonometers

Role: lead

NCT05742009Not ApplicableCompleted

iCare ST500 Clinical Trial

Role: lead

NCT05940623Not ApplicableUnknown

Impact of Home Intraocular Pressure Telemonitoring on Intraocular Pressure Control and Glaucoma Progression

Role: collaborator

NCT05162989Not ApplicableCompleted

iCare HOME2 Clinical Trial

Role: lead

NCT04384094Unknown

Defining the Operating Parameters for a Rebound-esthesiometer

Role: lead

NCT01159340Completed

Icare Versus Haag-Streit Applanation Tonometer

Role: lead

All 10 trials loaded